Brief: Spectracure FDA Has Approved Co's New Protocol For Clinical Trials
March 16 (Reuters) - SpectraCure AB (publ) SPEC.ST :
* SPECTRACURE AB (PUBL) - FDA HAS APPROVED CO'S NEW PROTOCOL FOR CLINICAL TRIALS
Source text for Eikon: ID:nWkr5XbhfV
Further company coverage: SPEC.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))